This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Heart Failure Hypertension Outcomes 
Frontiers in Cardiovascular Medicine
JANUARY 28, 2025
Care for survivors after an acute attack of COVID-19 should include paying close attention to cardiovascular health and disease.Systematic Review RegistrationPROSPERO [CRD42022353965].
95 
Heart BMJ
MARCH 26, 2025
Heart failure (HF) is one of the significant complications in patients with myocardial infarction (MI), leading to increased risk for cardiovascular morbidity and mortality. 2 Therefore, early identification of HF in high-risk populations, particularly post-MI, is essential for improving outcomes. HFrEF is more commonly.
DAIC
MAY 6, 2024
The primary outcome measure for the study is change in six-minute walk distance from Baseline to Week 12. Initially discovered and developed by Orion Corporation in Finland, intravenous levosimendan is approved in 60 countries outside the United States for use in hospitalized patients with acutely decompensated heart failure.
Frontiers in Cardiovascular Medicine
JULY 24, 2024
Chronic Thromboembolic Pulmonary Hypertension (CTEPH) is a severe and complex condition that evolves from unresolved pulmonary embolism, leading to fibrotic obstruction of pulmonary arteries, pulmonary hypertension, and potential right heart failure.
98 
Frontiers in Cardiovascular Medicine
MARCH 30, 2025
Demographic, clinical, and diagnostic data, as well as follow-up outcomes, were reviewed. Infection (75.47%, 160/212) and heart failure (51.42%, 109/212) were common comorbidities. Patients with RP-HCM showed the poorest outcomes, with a follow-up mortality rate of 42.86%.
52 
Open Heart
MAY 23, 2024
Background and aims Pre-eclampsia complicates 3–5% of pregnancies worldwide and is associated with adverse outcomes for the mother and the offspring. Pre-eclampsia and heart failure have common risk factors, including hypertension, obesity and diabetes.
European Journal of Heart Failure
FEBRUARY 5, 2025
Methods and results TRED-HF was a randomized trial investigating heart failure therapy withdrawal in patients with recovered DCM over 6months. Clinical outcomes are reported in a non-randomized fashion from enrolment and from the end of the trial.
Journal of the American Heart Association
FEBRUARY 3, 2025
Journal of the American Heart Association, Ahead of Print. BackgroundDespite the poor outcomes related to the presence of pulmonary hypertension, it often goes undiagnosed in part because of low suspicion and screening tools not being easily accessible such as echocardiography.
68 
Open Heart
JUNE 1, 2022
Objectives We aim to assess the association of cardiovascular medications with outcomes of patients referred to the diagnostic heart failure (HF) clinic with symptoms or signs of possible HF, raised N-terminal pro-brain-type natriuretic peptide (NT-proBNP) but no evidence of HF on transthoracic echocardiography (TTE).
Hypertension Journal
NOVEMBER 22, 2023
Hypertension, Ahead of Print. BACKGROUND:Diabetes is an important risk factor for heart failure (HF) and is associated with left ventricular (LV) diastolic dysfunction. However, diabetic comorbid conditions, such as nocturnal hypertension, as predictors of diastolic dysfunction are not known in the absence of an HF period.
40 
European Journal of Heart Failure
SEPTEMBER 26, 2023
Abstract Diagnosing heart failure is often difficult due to the non-specific nature of symptoms, which can be caused by a range of medical conditions. Natriuretic peptides (NPs) have been recognized as important biomarkers for diagnosing heart failure. Use of this acronym would enable the early diagnosis of heart failure.
Journal of the American Heart Association
DECEMBER 29, 2023
Journal of the American Heart Association, Ahead of Print. BackgroundPulmonary hypertension (PH) is highly prevalent in patients with heart failure with preserved ejection fraction (HFpEF), and it is a strong predictor of adverse outcomes.
Circulation
MARCH 9, 2025
Albuminuriaincreased urine albumin excretionis associated with cardiovascular mortality among patients with diabetes, hypertension, chronic kidney disease, or heart failure, as well as among adults with few cardiovascular risk factors. Circulation, Volume 151, Issue 10 , Page 716-732, March 11, 2025.
Circulation: Heart Failure
MARCH 5, 2025
Circulation: Heart Failure, Ahead of Print. BACKGROUND:Exercise-induced hypertension (EIH) is common in adults with coarctation of the aorta (COA), but there are limited data about hemodynamics and outcomes in such patients.
40 
Circulation
NOVEMBER 11, 2024
Background:Stage B heart failure (HF) was associated with increased cardiovascular and HF events. Hypertension is a risk factor for these events in Stage B HF. Conclusions:Elevated nighttime home BP was a significant predictor for cardiovascular outcomes in stage B HF patients. 3.65, p=0.02).Conclusions:Elevated
Circulation
NOVEMBER 11, 2024
Background:Heart failure (HF) is one of the leading causes of hospitalizations in the States. Patients with hyperkalemia had a higher frequency of diabetes mellitus, hypertension, chronic liver disease, acute kidney injury, chronic kidney disease, end-stage renal disease, and acute encephalopathy (p<0.001). 2], p<0.001).Conclusion:Hyperkalemia
40 
Journal of the American Heart Association
DECEMBER 29, 2023
The influence of the valsartan recall on clinical outcomes is unknown. Hypertensive patients who received valsartan or nonrecalled angiotensin receptor blockers/angiotensin‐converting enzyme inhibitors for 1 year before and on the recall date were compared. 1.04]) and the composite of cardiac events (HR, 1.22 [95% CI, 1.15–1.29])
45 
DAIC
JUNE 11, 2024
Tricuspid and mitral valves are debilitating conditions that can lead to arrhythmias, hypertension, and heart failure. Leon added, “This new mitral-tricuspid valve center will mobilize a decade of specialized experiences among our contributing physicians to provide optimal clinical outcomes for our sickest patients.”
111 
HeartRhythm
APRIL 30, 2024
Introduction: Patients with ‘heart failure with preserved ejection fraction’ (HFpEF) frequently manifest chronotropic incompetence as well as hypertension (HTN). Cardiac pacing may improve clinical outcomes in these patients. To date, pacing has not been regulated by an external hemodynamic input.
European Journal of Heart Failure
DECEMBER 7, 2023
Increasing severity of obesity is associated with multiple characteristics that may contribute to the development or worsening of heart failure (HF) with preserved ejection fraction (HFpEF). Obesity was associated with more first and recurrent heart failure events. Overall, 60.9% of patients had BMI ≥30 kg/m 2.
Heart BMJ
OCTOBER 10, 2024
Indeed, numerous studies are currently investigating the impact of such approaches on clinical outcomes and healthcare utilisation. Accordingly, the management of AF has shifted towards a holistic and integrated approach, targeting comorbidities and risk factors, itself associated with improved outcomes. 2 Before the.
Journal of the American Heart Association
MARCH 27, 2025
The primary outcome was a composite of inhospital adverse events. Associations between multimorbidity patterns and outcomes were evaluated using multivariableadjusted logistic regression models. years]) admitted to the China Chest Pain Center Database between 2016 and 2021. Among 9570 patients, 50% (n=4789) had multimorbidity.
Open Heart
FEBRUARY 17, 2024
Objective To evaluate stress, depression and quality of life among community-dwelling patients with heart failure (HF) and evaluate their effect on perceived medication adherence in a socioeconomically challenged setting.
Frontiers in Cardiovascular Medicine
MAY 8, 2024
Pulmonary arterial hypertension (PAH) is a chronic and progressive disease that eventually leads to heart failure (HF) and subsequent fatality if left untreated. Right ventricular (RV) function has proven prognostic values in patients with a variety of heart diseases including PAH.
40 
Stroke Journal
JANUARY 30, 2025
Propensity score-matched analysis (PSM) (1:1) was performed on age, gender, BMI, hypertension, diabetes mellitus, chronic kidney disease, hemoglobin level, LDL level, left ventricular ejection fraction and various drugs including beta blockers, ACEi and ARBi. The mean age of patients was comparable between both groups (59.8
Stroke Journal
JANUARY 30, 2025
Propensity score-matched analysis (PSM) (1:1) was performed with matching for age, gender, race, BMI, hypertension, diabetes mellitus, chronic kidney disease, hemoglobin level, low-density lipid (LDL) level, left ventricular ejection fraction, and various drugs including ACEi, ARBi, ARNI, beta-blockers, and diuretics.
40 
Heart BMJ
DECEMBER 20, 2023
Hypertension is the single most important risk factor for development of atrial fibrillation (AF), which may be considered as a cardiac manifestation of hypertensive target organ damage. Furthermore, coexistence of hypertension and AF mutually amplifies the risk of complications, such as heart failure and stroke.
DAIC
JUNE 27, 2024
By leveraging Anumana's ECG-AI algorithms, developed and validated in collaboration with Mayo Clinic, this initiative aims to enhance InfoBionic.Ai’s MoMe ARC Platform’s ability to detect and intervene in cardiac diseases earlier in the remote patient monitoring setting, with the potential to improve patient outcomes.
105 
Circulation
NOVEMBER 11, 2024
Intro:Drug Development for Heart failure with Preserved Ejection Fraction (HFpEF) is a major challenge facing cardiovascular research due to its complex pathophysiology and existence of comorbidities, leading to recognize distinct HFpEF phenogroups. Circulation, Volume 150, Issue Suppl_1 , Page A4139791-A4139791, November 12, 2024.
DAIC
FEBRUARY 29, 2024
This year’s theme, “Advancing Cardiovascular Care for All” brings the latest practice-changing breakthroughs, along with top experts debating and discussing outcomes of highly-anticipated clinical trials. 24 from April 6 - 8, 2024 in Atlanta, GA at the Georgia World Congress Center.
103 
Stroke Journal
JANUARY 30, 2025
Background:The STRACK project aims to improve post-stroke patient management and the transition from acute to primary care thanks to improvements in patient pathways and monitoring cardiovascular risk factors: heart failure, diabetes, atrial fibrillation, dyslipidemia and hypertension.
40 
DAIC
JULY 15, 2024
Health systems leveraging Guidehealth can seamlessly integrate Story Health’s program to support at-risk patients with heart conditions like heart failure, hypertension, and arrhythmia, providing better care while also reducing the total cost of care, according to a written statement detailing the deal.
105 Journal of the American Heart Association
DECEMBER 29, 2023
AF increases the risk of stroke, heart failure, dementia, and hospitalization. Obesity significantly increases AF risk, both directly and indirectly, through related conditions, like hypertension, diabetes, and heart failure. ABSTRACTAtrial fibrillation (AF) is the most common cardiac arrhythmia.
45 
Heart BMJ
MAY 10, 2024
Hospitalisation due to this condition is exponentially growing, and now outnumbers those for both heart failure and myocardial infarction. Hospitalisation due to this condition is exponentially growing, and now outnumbers those for both heart failure and myocardial infarction.
40 Stroke: Vascular and Interventional Neurology
NOVEMBER 9, 2023
Diabetes is a risk factor for acute ischemic stroke and also a poor predictor of outcome for many interventional surgeries. We performed this retrospective cohort analysis to assess the impact of poorly controlled diabetes, defined as HbA1C of 9.0% or greater. vs. 20.5%; p = 0.048) and stenting (28.4%
40 
Stroke Journal
JANUARY 30, 2025
Migraine with aura(MwA) is associated with an increased risk of stroke and adverse vascular outcomes compared to those with migraine without aura (MwoA). Patients with any adverse vascular outcomes before the index ECG were excluded. The prevalences of all vascular outcomes are summarized in Table 1. p < 001).
Hypertension Journal
JULY 14, 2023
Hypertension, Ahead of Print. Dysregulation of β-arrestin signaling has been linked to several cardiovascular diseases including hypertension, atherosclerosis, and heart failure. β-arrestins are a family of intracellular signaling proteins that play a key role in regulating the activity of G protein-coupled receptors.
Journal of the American Heart Association
FEBRUARY 26, 2025
Journal of the American Heart Association, Ahead of Print. BackgroundMultimorbidity is common among patients with atrial fibrillation (AF) and is associated with worse outcomes. AF symptom severity was assessed via the University of Toronto AF Severity Scale questionnaire.
ADN Center of Excellence
SEPTEMBER 2, 2024
AFib is associated with a fivefold increased risk of stroke, and it is also linked to heart failure, chronic fatigue, and other serious health issues. Factors such as aging populations, rising rates of obesity, hypertension, and other cardiovascular conditions contribute to this increase. www.adncoe.com
59 Journal of the American Heart Association
FEBRUARY 25, 2025
BackgroundPeripartum cardiomyopathy (PPCM) is a rare medical condition presenting as idiopathic heart failure. For chronic hypertension in NonHispanic Black births there was a slight decrease in odds from 3.4
Vector Remote
MARCH 9, 2023
All About Cardiac Remote Patient Monitoring Software Comprehensive healthcare for rhythm, heart failure, and hypertension requires the ability to monitor a heart’s condition. RPM solutions are improving healthcare outcomes and helping patients lead healthier lives.
Journal of Cardiovascular Pharmacology
FEBRUARY 1, 2024
Cardiac fibrosis is considered as unbalanced extracellular matrix (ECM) production and degradation, contributing to heart failure. Cardiac fibrosis is considered as unbalanced extracellular matrix (ECM) production and degradation, contributing to heart failure.
40 
European Journal of Heart Failure
SEPTEMBER 15, 2023
Aims Patients with heart failure usually have several other medical conditions that might alter the effects of interventions. A prior history of the following comorbidities was considered: episodic or persistent atrial fibrillation ( n = 920), coronary artery disease ( n = 3732), diabetes ( n = 2171), and hypertension ( n = 3353).
ADN Center of Excellence
SEPTEMBER 2, 2024
AFib is associated with a fivefold increased risk of stroke, and it is also linked to heart failure, chronic fatigue, and other serious health issues. Factors such as aging populations, rising rates of obesity, hypertension, and other cardiovascular conditions contribute to this increase. www.adncoe.com
52
Expert insights. Personalized for you.
We have resent the email to
Are you sure you want to cancel your subscriptions?
Let's personalize your content